In mild to moderate COVID-19, VV116 safely reduced time to sustained clinical symptom resolution. Granwehr BP. Ann Intern Med 2024 Mar 5. doi: 10.7326/J24-0006.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Granwehr BP. In mild to moderate COVID-19, VV116 safely reduced time to sustained clinical symptom resolution. Ann Intern Med 2024 Mar 5. doi: 10.7326/J24-0006.
PMID: 38437701